Précis: 240-degree and 360-degree goniotomy (GT) demonstrated similar efficacy in intraocular pressure (IOP) reduction, both outperforming 120-degree GT in patients with juvenile open angle glaucoma (JOAG) at postoperative 6-month follow-up. Objective: To compare the surgical efficacy and safety of 120-degree, 240-degree, and 360-degree GT for patients with JOAG. Patients and Methods: This multicenter retrospective study included 102 eyes of 102 patients with JOAG, who underwent GT with a follow-up of at least 6 months. Patients were categorized into 3 groups: (1) 120-degree GT, (2) 240-degree GT, and (3) 360-degree GT. IOP, glaucoma medications, and complications were recorded at baseline and the final visit. Complete success and qualified success were defined as a postoperative IOP ≤21 mm Hg without and with medications, respectively. Results: Mean age of the participants was 24.4 ± 7.9 years. After a mean follow-up of 8.1 ± 2.7 months, complete success rates were similar between the 240-degree GT (45.2%) and the 360-degree GT (63.2%; P = 0.135), and both were superior to 120-degree GT (18.2%; P < 0.05). Qualified success rates among patients in the 120-degree, 240-degree, and 360-degree GT groups were 93.9%, 96.8%, and 100%, respectively, and showed no statistically significant difference (P = 0.292). 360-degree GT required fewer medications than 240-degree GT and 120-degree GT (P < 0.05), with no significant difference in medications between 120-degree GT and 240-degree GT (P > 0.05). Hyphema was the most common postoperative complication, with a significantly higher incidence in the 360-degree GT (68.4%) compared with the 240-degree GT (41.9%) and 120-degree GT (33.3%; P < 0.05). Conclusions: 240-degree and 360-degree GT showed similar efficacy in IOP reduction and were superior to 120-degree GT. More extensive GT may provide better outcomes in JOAG.
P16-Negative, High-Risk Human Papilloma Virus-Associated Penile Squamous Cell Carcinomas
TORREY Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension (PAH): Circulating Biomarkers of Proliferation, Inflammation and Fibrosis Improve with Treatment
Subgruppenanalyse der Lungenfunktion bei Patientinnen und Patienten mit nicht durch Cystische Fibrose verursachter Bronchiektasen-Erkrankung in der randomisierten, doppleblinden, placebokontrollierten Phase-3-Studie ASPEN
Subgruppenanalyse der jahrlichen Exazerbationsrate bei Patientinnen und Patienten mit Bronchiektasen-Erkrankung ohne Cystische Fibrose in der randomisierten, doppleblinden, placebokontrollierten Phase-3-Studie ASPEN
Background: The primary aim of this study was to demonstrate the benefits of topical human platelet exosome extract (HPE) (plated) hair serum for improving hair and scalp health in participants with self-perceived thinning hair. Methods: This single-center, placebo-controlled, double-blind study enrolled 39 healthy men and women 18–65 years of age with self-perceived thinning hair. Participants applied either HPE for 9 months or a topical placebo for 6 months with the option to cross over to HPE at 6 months for an additional 3 months. End points included improvements in the global aesthetic appearance of hair, as assessed by a blinded live evaluator; participant-reported outcomes; hair trichoscopy; and independent physician photograph evaluations. Safety data included monitoring for adverse events. Results: Blinded live evaluator assessments demonstrated statistically significant improvements in the global aesthetic appearance of hair for volume/fullness, density, scalp coverage, and appearance, with all P values less than 0.0001 within the HPE group and statistical improvement over the control at months 3 and 6 for volume/fullness, density, and scalp coverage. Participant-reported outcomes for within-group changes for HPE were statistically significant for all hair health parameters, including density, volume fullness, scalp coverage, scalp health, thickness, amount, quality, color, dryness, strength, and overall health of the hair. Hair trichoscopy analyses were significantly improved from baseline within the HPE group. Independent physician photography review demonstrated greater improvements within the HPE group. No adverse effects were observed. Conclusions: This study demonstrates that topical HPE (plated) hair serum with Renewosome technology significantly improves hair and scalp health and is safe and well tolerated.
Impact of nuclear fragmentation and irradiation scenarios on the dose‐averaged LET, the RBE, and their relationship for H, He, C, O, and Ne ions
Abstract Background Projectile and target fragmentation are nuclear phenomena that can influence the computation of the linear energy transfer (LET) and the relative biological effectiveness (RBE) in external radiotherapy with accelerated ions. Correlations between these two quantities are routinely established during radiobiological experiments to interpret the results and to develop and calibrate RBE models. Purpose This study systematically evaluates the impact of secondary fragments and irradiation scenarios on the dose‐averaged LET, the RBE, and their correlation in the case of exposures to clinically relevant ion beams. Methods 57 600 microdosimetric lineal energy spectra and corresponding LET distributions were simulated with the Monte Carlo code PHITS across different scenarios, including track segment calculations, pristine, and spread‐out Bragg peaks of 1 H, 4 He, 12 C, 16 O, and 20 Ne ions within water phantoms. The LET distributions were analyzed to calculate the dose‐average LET, both including or excluding the contribution of secondary ions of an element different from the primary beam. Similarly, the lineal energy distributions were processed in conjunction with the Mayo Clinic Florida microdosimetric kinetic model to compute the RBE for two theoretical cell lines ( α / β = 2 and 10 Gy in the case of 6 MV x‐rays). Correlations between the RBE and dose‐averaged LET were established by analyzing the simulation results within water phantoms and then compared to the corresponding trends from the track segment calculations. Results Excluding secondary fragments had a pronounced impact on the dose‐averaged LET and the RBE, particularly in the entrance regions of proton beams and close to the distal edge of heavier ions. The correlations between the RBE and the dose‐averaged LET were not universal, but highly dependent on the irradiation scenario. For proton beams only, the dose‐averaged LET of hydrogen ions served as a practical first‐order descriptor of the RBE. Track segment simulations, commonly used for calibrating and benchmarking RBE models, provided a reasonable approximation for low‐energy beams but failed to fully capture the complexity of polyenergetic radiation fields. Conclusions Secondary fragments can substantially affect the dose‐averaged LET and the RBE, even in proton beams. The dose‐averaged LET, including or not the contributions from secondary fragments, was generally unable to adequately capture RBE variations across different scenarios. A more comprehensive approach, considering microdosimetric distributions, is necessary to accurately describe RBE variations in ion therapy.
Follicular helper- and peripheral helper-like T cells drive autoimmune disease in human immune system mice
Abstract Human immune system (HIS) mice constructed in various ways are widely used for investigations of human immune responses to pathogens, transplants and immunotherapies. In HIS mice that generate T cells de novo from hematopoietic progenitors, T cell-dependent multisystem autoimmune disease occurs, most rapidly when the human T cells develop in the native NOD.Cg- Prkdcscid Il2rgtm1Wjl (NSG) mouse thymus, where negative selection is abnormal. Disease develops very late when human T cells develop in human fetal thymus grafts, where robust negative selection is observed. We demonstrate here that PD-1+CD4+ peripheral (Tph) helper-like and follicular (Tfh) helper-like T cells developing in HIS mice can induce autoimmune disease. Tfh- like cells were more prominent in HIS mice with a mouse thymus, in which the highest levels of IgG were detected in plasma, compared to those with a human thymus. While circulating IgG and IgM antibodies were autoreactive to multiple mouse antigens, in vivo depletion of B cells and antibodies did not delay the development of autoimmune disease. Conversely, adoptive transfer of enriched Tfh- or Tph-like cells induced disease and autoimmunity-associated B cell phenotypes in recipient mice containing autologous human APCs without T cells. Tfh/Tph cells from mice with a human thymus expanded and induced disease more rapidly than those originating in a murine thymus, implicating HLA-restricted T cell-APC interactions in this process. Since Tfh, Tph, autoantibodies and lymphopenia-induced proliferation (LIP) have all been implicated in various forms of human autoimmune disease, the observations here provide a platform for the further dissection of human autoimmune disease mechanisms and therapies.